{"public_id":"co_41c9f4a781637a9193fb327f6f2582e2","status":"active","merged_into_public_id":null,"resolved_public_id":"co_41c9f4a781637a9193fb327f6f2582e2","name":"HO-3867","description":"A curcumin analog investigated for its effects on mutant p53 activity and anticancer activity.","aliases":["curcumin analog HO-3867"],"types":["compound","drug"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":4228513,"title":"The curcumin analog HO-3867 selectively kills cancer cells by converting mutant p53 protein to transcriptionally active wildtype p53","citation_count":40,"url":"https://sah.borca.ai/papers/4228513"}],"claims":[{"public_id":"cl_367a387f1cf61cb3667a64969504bda7","text":"HO-3867 covalently binds to mutant p53 and initiates a wildtype p53-like anticancer genetic response.","corpus_id":4228513,"url":"https://sah.borca.ai/claims/cl_367a387f1cf61cb3667a64969504bda7"},{"public_id":"cl_53500fe99876b28f71dbb327b54c2218","text":"HO-3867 is a p53 mutant-reactivating drug with high clinical anticancer potential.","corpus_id":4228513,"url":"https://sah.borca.ai/claims/cl_53500fe99876b28f71dbb327b54c2218"},{"public_id":"cl_c65cf404cb103a361d3d5d44bec66fa6","text":"HO-3867 is exclusively cytotoxic toward cancer cells.","corpus_id":4228513,"url":"https://sah.borca.ai/claims/cl_c65cf404cb103a361d3d5d44bec66fa6"},{"public_id":"cl_fd3f0237cd7cea28131ad2c44e29e56f","text":"HO-3867 exhibits high anticancer efficacy in tumor models.","corpus_id":4228513,"url":"https://sah.borca.ai/claims/cl_fd3f0237cd7cea28131ad2c44e29e56f"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_41c9f4a781637a9193fb327f6f2582e2","url":"https://sah.borca.ai/concepts/co_41c9f4a781637a9193fb327f6f2582e2"}